The amino acid methionine is considered essential in human metabolism (1). Nevertheless, it is common in experiments with cultured cells to limit or omit non-radioactive methionine from normal growth media as a means of increasing incorporation of added radioactive [S}methion-me into newly synthesized proteins. In most cell lines (fibroblasts or lymphoblastoid lines, for example), this treatment appears to have little or no effect on the pattern of protein synthesis over the brief (<1 to 18 h) labeling periods used. In some human-cell lines, however, we have observed a series of specific protein alterations after transfer to methionine-deficient media, which suggest interesting relationships between methionine metabolism and differentiation. The effect involves primarily the appearance of a set of novel polypeptides we have called the "Metmin" group, and diminished accumulation of principal nuclear proteins. These effects are accompanied by morphological changes that ultimately lead to cell death.
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Effects Regulatable aspects of methionine metabolism have been extensively studied in hopes of clariQying the puzzling differences in methionine utilization by normal and some tumor cells (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Tetrahydropteroylglutamate methyltransferase (EC 2.1.1.13, methionine synthase), for instance, can be induced by folate, methionine, or vitamin B12 (10) . In addition, there is evidence that methionine metabolism differs considerably among in vitro cell lines, and between fetal and adult tissues. Tisdale (3, 4) and others (14) have shown that some tumor lines display an absolute requirement for the preformed methyl groups of methiomne, whereas most untransformed cells appear to be able to use homocysteine in combination with 5-methyltetrahydrofolate and vitamin B12, the substrates and cofactor required for enzymatic regeneration of methiomne. Tisdale concludes that the methionine-requiring Walker-carcinoma line is likely to have a very high consumption of methionine rather than a defect in its metabolism (3), although the methionine sink in such cells remains unidentified. Normal fetal and adult human liver tissue also differ in some aspects of methiomne metabolism; methionine synthase activity is twice as great in the livers of premature infants as in livers of adults (15) , and the other folate enzymes are altered as well. Methionine metabolism is thus expected to be regulatable by extracellular conditions and to vary, sometimes substantially, among cell types.
The participation of SAM in DNA methylation suggests that methionine starvation could result in hypomethylation of newly synthesized DNA during cell division. Any such effect could influence the expression of a variety of genes. Studies of the inducibility of the mouse metallothionine-I gene by cadmium (16), and of the relative levels of expression of ovalbumin in chicken oviduct vs liver (17) and of human globin genes in various cell types (18) suggest that the decreased DNA methylation is related to increased expression of those genes. Experimental manipulations designed to induce hypomethylation of DNA, in particular treatment with the drug 5-azacytidine (5-AC), have been shown to derepress several genes on previously silent copies of an X-chromosome (19); to cause mouse embryo cells to form myotubes, chondrocytes, and adipocytes (20); to produce macrophage-like cells from a mouse pro-B lymphoma (21) ; and to increase expression of total Hb in human thalassemia patients (22 cates that many genes are sensitive to DNA methylation effects and that some of these genes are related to differentiation. The ability of 5-AC, an inhibitor of DNA-methylase enzyme (24), to cause hypomethylation by a pathway presumably quite different from any direct effect on the availability of methionine makes it possible for us to show that the expression of Metmin proteins may be more closely related to effects of hypomethylation than to the metabolism of the amino acid itself.
Our interest in methionine starvation and the possible mechanisms by which its effects are generated stems from experiments on the cell line HL-60, derived from a human promyelocytic leukemia (25). This line can be made to differentiate in vitro by treatment with phorbol ester tumor promoters such as phorbol myristate acetate (PMA), yielding a cell that in many respects resembles a macrophage (26) . By analyzing the proteins synthesized by HL-60 cells with and without PMA treatment, we discovered a series of differences that we initially attributed to differentiation. However, because methionine-deficient media were used in the first experiments, only later, with the inclusion of complete-medium controls, did it become clear that some of the major differences were attributable to the effects of methionine starvation on the untreated HL-60 cells. These include effects that never appeared in the PMA-treated, differentiated cells. The intriguing possibility that such a basic difference may reveal an important defect in the methiomne metabolism of HL-60-and, as we discovered later, other PMA-responsive human cell lines-led us to examine the phenomenon in greater detail.
Materials and Methods
Cell culture. HL-60 cells were obtained from both Dr. E. Samples of cellular proteins were prepared by dissolving cells in a solubilizing solution containing, per liter, 9 mol of urea, 20 mL of NP-40, 10 mL of 2-mercaptoethanol, and 20 mL of ampholytes (pH 9-11; LKB Instruments, Gaithersburg, MD 20877). Twodimensional electrophoresis was performed as described previously, with the 18 x 18 cm ISO-DALT system (27, 28) , and with ampholytes consisting of a mixture of 1 part pH 3.5-5 and nine parts pH 3.5-10 (LKB). Gels were stained, destained, dried, and exposed to KOdak XAR film for autoradiography. Quantitation of spots was performed with the TYCHOI computer system (29).
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Results
MethionineStarvation Results in the Appearance of a
Set of Novel Proteins in HL-60 Cells
Culture of HL-60 cells for 24 h in RPMI 1640 medium lacking methionine (aside from that contained in the added fetal bovine serum or added as radiolabel) results in the appearance of a specific set of at least seven major polypeptides visible on two-dimensional gels ( Figure 1 , Table 1 ).
These proteins are not observed in cells starved similarly for leucine or phenylalanine, which are taken up by the same transport system as is used for methionine (system L, ref. Homocysteine alone does not prevent starvation when it is used to supplement methionine-deficient medium that is more than a few weeks old, at which time the medium seems to be essentially folate-free. Starvation for glucose, treatment with hydroxyurea, sulihydryl poisons, the protein synthesis inhibitor cycloheximide, or the RNA-polymerase inhibitor a-amanitin do not produce the effect.
The set of proteins appearing as a result of methionine starvation does not include proteins associated with other well-known sets such as the heat-shock (33), mitochondrial proteins probably were produced during labeling of leukocyte samples in methionine-deficient medium rather than in vivo. Based on the novelty of most of the methiomnestarvation protein set, we denote its members as Metmin:1-8 in accordance with the nomenclature for protein sets used previously (29). Pulse-labeling experiments designed to investigate the "induction" of Metmin "synthesis" showed instead that these proteins are likely to be the products of the modification of pre-existing normal cellular proteins. HL-60 cells pre-labeled in complete medium and then 3 (N:1-3) in Figure  1 ], although at least two other nuclear polypeptides do not appear to be affected. Nuc:1 is tentatively identified as Lamin B (30), a protein likely to be important in controlling nuclear architecture.
In addition, there are subtle but reproducible effects involving increased acidwards chargemodification of a highly conserved, lysine-poor, trimethyllysine-inducible protein ("Everlast," oval-encircled II in Figure 1B; N. L. A., unpublished) , and an upwards shift of part of the density associated with a major cytoplasmic phosphoprotein ("Tbird," oval-encircled I in Figure 1B; N. L. A.,  unpublished) . 
Localizationof Metmin Proteinsin HL-60 Cells
Cytoskeletal/nuclear cell fractions prepared by extraction of methionine-starved HL-60 cells with NP-40 contain a large proportion of the Metmin protein in the cell (Figure 3) . ;: e . .
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they are nuclear rather than attached to the cytoplasmic cytoskeleton ( Figure 3) . LDH-B and f32-microglobulin are evenly divided between the fractions, while Mitcon:2 is slightly enriched in karyoplasts, owing to the tendency of heavy mitochondria to partition into the denser, nucleuscontaining fragment of the cell. We carried out the enucleation experiments with cells showing less than maximal Metmin concentrations, in order to avoid the complications introduced into such procedures by the changes in cell morphology described below. in PMA-treated cells as compared with controls (both labeled in methionine-deficient medium) constitutes the largest class of differences observable in the PMA induction system. PMA induces a variety of other changes in I{L-60, presumably reflecting monocytoid differentiation, which are independent of Metmin effects-i.e., they occur in either methiomne-deficient or complete media (37) . Cells concurrently starved for methionine and treated with PMA for 24 h show only a slight diminution of Metmin production as compared with methionine-starved controls, suggesting that the PMA effect involves differentiational changes (taking at least a day) rather than rapid regulational changes (such as the PMA-induced protein phosphorylations, which usually are complete within several minutes of treatment).
Preventionof Metmin Productionin HL-60 Cells by Pretreatmentwith PhorbolMyristateAcetate
Methioninestarvation causes the appearance of Metmin proteins (Figure 4) in the cell line CCL-119, a T- 
Morphological Changes AccompanyingMetmin Production
The production of Metmin proteins is associated with the appearance of a peculiar altered morphology in some cells of the culture ( Figure 5) . As viewed by light microscopy, the nuclear material becomes dense, compact, and fragmented into a cluster of small bodies. The cell itself becomes similarly fragmented, and looks like a cluster of grapes. At this stage the cell/cluster still excludes Trypan Blue and is probably still at least partly functional. Other cells in the same culture can appear completely intact, and at least some of these are viable as evidenced by their ability to continue growth after restoration of methionine. The cell! clusters finally disperse into small independent globules, many of which retain a dense fragment of chromatin, and which appear to retain membrane integrity for one or more 
Discussion
A well-defined group of proteins (the Metmin set) is produced in cells of the human promyelocytic leukemia line HL-60 by either starvation for methiomne or treatment with 5-azacytidine.
A concomitant reduction in certain nuclear proteins is observed. The effect appears to be amino acid specific, since starvation for leucine, phenylalanine, or serine does not produce it. Homocysteine, an amino acid which can be S-methylated intracellularly to yield methionine, can substitute for methionine in Met-deficient medium so long as there is sufficient tetrahydrofolate (and vitamin B12) to provide regenerating methyl groups. Treatment with 5-AC results in Metmin production, but presumably by a different route, because the compound is not believed to participate in or inhibit methiomne or SAM biosynthesis. 5-AC does, however, irreversibly inactivate an important cellular user of SAM, namely the DNA methylase involved in maintaining symmetric methylation of CpG sequences in nuclear DNA (24) . The two main treatments capable of causing Metmin production are thus likely to have in common an inhibitory effect upon DNA methylation, due in one case to depletion of methyl-donating substrate (SAM) and in the other to inactivation of enzyme. Interesting morphological alterations occur in cultures subject to treatments associated with Metmin production, and these also point to effects in the nucleus. Initially a small number of cells begin to show condensed, and then fragmented, nuclei, followed by subdivision of the cell to give a bunch-of-grapes appearance. This change gradually appears in a larger proportion of the cells present, until all the cells are dispersed into a suspension of roughly spherical microcells, the whole process taking two to three days. Under the same treatment conditions, insusceptible cell types such as fibroblasts or typical lymphoblastoid lines show no evidence of this grape-cluster formation.
The nature of the Metmin-producing treatments, the location of the Metmin proteins, and the morphological changes associated with Metmin production all suggest a relationship between methionine metabolism and a series of protein-modification and structural events in the cell nucleus. The mechanism by which these effects are produced, and why they occur in some tumor cell lines and not in others, remains unclear, however. Several studies have found evidence of abnormal rates of methionine uptake and consumption by tumor cells. Tisdale (2, 3) , comparing the methionine-requiring Walker rat mammary carcinoma with other tumor cell lines, observed that substitution of homocysteine for methionine caused a cessation of growth in the Walker line attributable to higher methionine requirement, possibly linked to an enhanced methylating activity. Levels of both methionine-forming methionine synthase and SAM-using tRNA methylase were increased by methionine starvation. Tautt (43) . In the present context, we may note that these results are consistent with the hypothesis that SAM or methionine is being rapidly utilized for some unrecognized purpose in untreated HL-60, and that PMA-induced differentiation restricts this loss, leading to increased availability of SAM for various other uses.
A second hypothesis may explain how some of the effects of decreased methionine (and hence SAM) availability are manifested in sensitive cell lines. DNA synthesis does not appear to be stringently linked to methylation of new CpG sites, and thus does not stop abruptly upon withdrawal of methionine (7) . Nevertheless, mammalian cells apparently cannot, in general, continue replicating DNA for very long in the absence of methylation; indeed, this effect may explain in part the properties of 5-AC as a drug. A possible explanation of the morphological changes observed in methionine-starved HL-60 may be that these cells continue to synthesize DNA under circumstances in which it cannot be methylated. Accumulation of unmethylated DNA may disrupt nuclear structures, If the suspected relationship between susceptibility to the Metmin effect and PMA-responsiveness is confirmed, then we would expect by analogy that treatment with 5-AC should have a much more toxic effect on methionine-starvation-sensitive, PMA-sensitive cells than on normal ones. Only a few leukemias show high Metmin production under conditions of methionine starvation (44) , and these may be far more sensitive to the drug than the others. Since PMA responsiveness can be observed rather easily in most cases (causing attachment of cells to plastic culture dishes), this correlation might provide a useful predictive measure of the efficacy of 5-AC treatment.
These studies demonstrate the applicability of two-dimensional electrophoretic methods to the detailed analysis of pharmacological effects. They also suggest a new class of drug effects, namely specific cleavage of pre-existing cellular proteins in response to drug treatment.
